• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定量高通量筛选数据分析:挑战与最新进展

Quantitative high-throughput screening data analysis: challenges and recent advances.

作者信息

Shockley Keith R

机构信息

Biostatistics and Computational Biology Branch, The National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.

出版信息

Drug Discov Today. 2015 Mar;20(3):296-300. doi: 10.1016/j.drudis.2014.10.005. Epub 2014 Oct 23.

DOI:10.1016/j.drudis.2014.10.005
PMID:25449657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4375054/
Abstract

In vitro HTS holds much potential to advance drug discovery and provide cell-based alternatives for toxicity testing. In quantitative HTS, concentration-response data can be generated simultaneously for thousands of different compounds and mixtures. However, nonlinear modeling in these multiple-concentration assays presents important statistical challenges that are not problematic for linear models. The uncertainty of parameter estimates obtained from the widely used Hill equation model can be extremely large when using standard designs. Failure to properly consider standard errors of these parameter estimates would greatly hinder chemical genomics and toxicity testing efforts. In this light, optimal study designs should be developed to improve nonlinear parameter estimation; or alternative approaches with reliable performance characteristics should be used to describe concentration-response profiles.

摘要

体外高通量筛选在推进药物发现以及为毒性测试提供基于细胞的替代方法方面具有很大潜力。在定量高通量筛选中,可以同时为数千种不同的化合物和混合物生成浓度-反应数据。然而,这些多浓度测定中的非线性建模带来了重要的统计挑战,而线性模型则不存在这些问题。使用标准设计时,从广泛使用的希尔方程模型获得的参数估计值的不确定性可能极大。未能正确考虑这些参数估计值的标准误差将极大地阻碍化学基因组学和毒性测试工作。有鉴于此,应开发最佳研究设计以改进非线性参数估计;或者应使用具有可靠性能特征的替代方法来描述浓度-反应曲线。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90dc/4375054/800fdd5b7c9b/nihms641404f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90dc/4375054/800fdd5b7c9b/nihms641404f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90dc/4375054/800fdd5b7c9b/nihms641404f1.jpg

相似文献

1
Quantitative high-throughput screening data analysis: challenges and recent advances.定量高通量筛选数据分析:挑战与最新进展
Drug Discov Today. 2015 Mar;20(3):296-300. doi: 10.1016/j.drudis.2014.10.005. Epub 2014 Oct 23.
2
Robust ridge regression estimators for nonlinear models with applications to high throughput screening assay data.用于非线性模型的稳健岭回归估计器及其在高通量筛选分析数据中的应用。
Stat Med. 2015 Mar 30;34(7):1185-98. doi: 10.1002/sim.6391. Epub 2014 Dec 10.
3
Identifying actives from HTS data sets: practical approaches for the selection of an appropriate HTS data-processing method and quality control review.从高通量筛选数据集中识别活性物质:选择合适的高通量筛选数据处理方法及质量控制审查的实用方法
J Biomol Screen. 2011 Jan;16(1):1-14. doi: 10.1177/1087057110389039. Epub 2010 Dec 15.
4
Using weighted entropy to rank chemicals in quantitative high-throughput screening experiments.在定量高通量筛选实验中使用加权熵对化学物质进行排名。
J Biomol Screen. 2014 Mar;19(3):344-53. doi: 10.1177/1087057113505325. Epub 2013 Sep 20.
5
Experimental designs and their recent advances in set-up, data interpretation, and analytical applications.实验设计及其在设置、数据解释和分析应用方面的最新进展。
J Pharm Biomed Anal. 2011 Sep 10;56(2):141-58. doi: 10.1016/j.jpba.2011.04.023. Epub 2011 May 6.
6
Robust Analysis of High Throughput Screening (HTS) Assay Data.高通量筛选(HTS)分析数据的稳健分析
Technometrics. 2013 May 1;55(2):150-160. doi: 10.1080/00401706.2012.749166.
7
Large sample inference for an assay quality measure used in high-throughput screening.用于高通量筛选的分析质量指标的大样本推断。
Pharm Stat. 2011 May-Jun;10(3):227-31. doi: 10.1002/pst.452. Epub 2010 Oct 8.
8
Novel trends in high-throughput screening.高通量筛选的新趋势。
Curr Opin Pharmacol. 2009 Oct;9(5):580-8. doi: 10.1016/j.coph.2009.08.004. Epub 2009 Sep 21.
9
Challenges in secondary analysis of high throughput screening data.高通量筛选数据二次分析中的挑战。
Pac Symp Biocomput. 2014:114-24.
10
Uncertainty quantification in ToxCast high throughput screening.ToxCast 高通量筛选中的不确定性量化。
PLoS One. 2018 Jul 25;13(7):e0196963. doi: 10.1371/journal.pone.0196963. eCollection 2018.

引用本文的文献

1
PLASMOpred: A Machine Learning-Based Web Application for Predicting Antimalarial Small Molecules Targeting the Apical Membrane Antigen 1-Rhoptry Neck Protein 2 Invasion Complex.PLASMOpred:一种基于机器学习的网络应用程序,用于预测靶向顶端膜抗原1-棒状体颈部蛋白2入侵复合物的抗疟小分子。
Pharmaceuticals (Basel). 2025 May 23;18(6):776. doi: 10.3390/ph18060776.
2
Binding Activity Classification of Anti-SARS-CoV-2 Molecules using Deep Learning Across Multiple Assays.利用深度学习对跨多种检测方法的抗SARS-CoV-2分子的结合活性进行分类
Balkan Med J. 2024 May 3;41(3):186-192. doi: 10.4274/balkanmedj.galenos.2024.2024-1-73. Epub 2024 Mar 11.
3

本文引用的文献

1
Beyond IC: Towards Robust Statistical Methods for Association Studies.超越全基因组关联研究:迈向关联研究的稳健统计方法
J Pharmacogenomics Pharmacoproteomics. 2014 Mar 1;5(1):1000121. doi: 10.4172/2153-0645.1000121.
2
Inconsistency in large pharmacogenomic studies.大型药物基因组学研究中的不一致性。
Nature. 2013 Dec 19;504(7480):389-93. doi: 10.1038/nature12831. Epub 2013 Nov 27.
3
Using weighted entropy to rank chemicals in quantitative high-throughput screening experiments.在定量高通量筛选实验中使用加权熵对化学物质进行排名。
AI in drug discovery and its clinical relevance.
人工智能在药物研发中的应用及其临床意义。
Heliyon. 2023 Jul;9(7):e17575. doi: 10.1016/j.heliyon.2023.e17575. Epub 2023 Jun 26.
4
Accounting for Artifacts in High-Throughput Toxicity Assays.高通量毒性检测中的伪像分析。
Methods Mol Biol. 2022;2474:155-167. doi: 10.1007/978-1-0716-2213-1_15.
5
Chemoinformatic Analysis of Psychotropic and Antihistaminic Drugs in the Light of Experimental Anti-SARS-CoV-2 Activities.基于实验性抗SARS-CoV-2活性对精神药物和抗组胺药物的化学信息学分析
Adv Appl Bioinform Chem. 2021 Apr 12;14:71-85. doi: 10.2147/AABC.S304649. eCollection 2021.
6
Rethinking drug design in the artificial intelligence era.人工智能时代的药物设计再思考。
Nat Rev Drug Discov. 2020 May;19(5):353-364. doi: 10.1038/s41573-019-0050-3. Epub 2019 Dec 4.
7
Quality Control of Quantitative High Throughput Screening Data.定量高通量筛选数据的质量控制
Front Genet. 2019 May 9;10:387. doi: 10.3389/fgene.2019.00387. eCollection 2019.
8
Uncertainty quantification in ToxCast high throughput screening.ToxCast 高通量筛选中的不确定性量化。
PLoS One. 2018 Jul 25;13(7):e0196963. doi: 10.1371/journal.pone.0196963. eCollection 2018.
9
Dose-Related Severity Sequence, and Risk-Based Integration, of Chemically Induced Health Effects.化学诱导健康效应的剂量相关严重程度序列和基于风险的综合评估。
Toxicol Sci. 2018 Sep 1;165(1):74-89. doi: 10.1093/toxsci/kfy124.
10
Identification of small molecule inhibitors targeting the SMARCA2 bromodomain from a high-throughput screening assay.从高通量筛选试验中鉴定针对 SMARCA2 溴结构域的小分子抑制剂。
Acta Pharmacol Sin. 2018 Sep;39(9):1544-1552. doi: 10.1038/aps.2017.188. Epub 2018 May 24.
J Biomol Screen. 2014 Mar;19(3):344-53. doi: 10.1177/1087057113505325. Epub 2013 Sep 20.
4
Robust Analysis of High Throughput Screening (HTS) Assay Data.高通量筛选(HTS)分析数据的稳健分析
Technometrics. 2013 May 1;55(2):150-160. doi: 10.1080/00401706.2012.749166.
5
Statistical properties of an early stopping rule for resampling-based multiple testing.基于重抽样的多重检验早期停止规则的统计特性。
Biometrika. 2012 Dec;99(4):973-980. doi: 10.1093/biomet/ass051. Epub 2012 Oct 3.
6
The Tox21 robotic platform for the assessment of environmental chemicals--from vision to reality.Tox21 机器人平台用于评估环境化学物质——从愿景到现实。
Drug Discov Today. 2013 Aug;18(15-16):716-23. doi: 10.1016/j.drudis.2013.05.015. Epub 2013 May 31.
7
Pharmacodynamic models: parameterizing the hill equation, Michaelis-Menten, the logistic curve, and relationships among these models.药效学模型:对希尔方程、米氏方程、逻辑斯蒂曲线进行参数化,以及这些模型之间的关系。
J Biopharm Stat. 2013 May;23(3):648-61. doi: 10.1080/10543406.2012.756496.
8
Improving the human hazard characterization of chemicals: a Tox21 update.改进化学物质的人类危害特征描述:Tox21 更新。
Environ Health Perspect. 2013 Jul;121(7):756-65. doi: 10.1289/ehp.1205784. Epub 2013 Apr 19.
9
Incorporating biological, chemical, and toxicological knowledge into predictive models of toxicity.
Toxicol Sci. 2012 Dec;130(2):440-1; author reply 442-3. doi: 10.1093/toxsci/kfs281. Epub 2012 Sep 14.
10
A three-stage algorithm to make toxicologically relevant activity calls from quantitative high throughput screening data.一种从高通量筛选数据中进行毒理学相关活性筛选的三阶段算法。
Environ Health Perspect. 2012 Aug;120(8):1107-15. doi: 10.1289/ehp.1104688. Epub 2012 May 10.